European Journal of Gastroenterology & Hepatology

Papers
(The H4-Index of European Journal of Gastroenterology & Hepatology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Paper Alert64
The safety and efficacy of rituximab in autoimmune hepatitis: a systematic review and quality assessment54
Ustekinumab concentrations shortly after escalation to monthly dosing may identify endoscopic remission in refractory Crohn’s disease46
String used for oesophageal capsule endoscopy: help or hindrance?38
Effectiveness and safety of newly introduced endoscopic submucosal dissection in a Western center: a real-life study30
Paper alert29
Fib-4 index predicts prognosis after achievement of sustained virologic response following direct-acting antiviral treatment in patients with hepatitis C virus infection27
Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites27
Mid- to long-term outcomes of initial transjugular intrahepatic portosystemic shunt versus anticoagulation for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome27
Long-term cumulative incidence of metachronous advanced colorectal neoplasia after colonoscopy and a novel risk factor: a cohort study26
Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease26
A comparative study on nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis at a university hospital25
Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation23
Upregulated NORAD is implicated in apoptosis, inflammation, and oxidative stress in ulcerative colitis through the nuclear factor-κappaB signaling20
Endoscopic retrograde cholangiopancreatography discharge tool combined with rapid trypsinogen-2 test to predict same-day discharge: a prospective cohort study19
Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver disease19
Metabolic associated fatty liver disease and acute-on-chronic liver failure: common themes for common problems18
Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: a meta-analysis17
0.033783912658691